Supplementary Figure 1 from Phase II Study of Eribulin plus Pembrolizumab in Metastatic Soft-tissue Sarcomas: Clinical Outcomes and Biological Correlates
crossref（2024）
摘要
Supplementary Figure 1. Change in sum of longest tumor diameters across response assessments in liposarcoma and UPS/Other cohorts.
查看译文
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要